NEW YORK (GenomeWeb News) – Becton Dickinson today reported $1.97 billion in revenues for its fiscal fourth quarter, down 1 percent from a year ago but in line with the consensus Wall Street estimate.

The company reported revenues of $1.99 billion in the year ago period. On a currency neutral basis revenues were up about 5 percent year over year, BD said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.